Semiconductor Stocks: Micron Technology (NASDAQ:MU), Integrated Silicon Solution (NASDAQ:ISSI), Spansion Inc. (NYSE:CODE), Netlist (NASDAQ:NLST)

Trade-Ideas LLC identified Micron Technology Inc. (NASDAQ:MU) as a pre-market laggard candidate. Micron Technology, Inc. (NASDAQ:MU) stock performance was -1.12% in last session and finished the day at $24.83. Traded volume was 25.96million shares in the last session and the average volume of the stock remained 35.75million shares. The beta of the stock remained 1.86. Micron Technology, Inc. (NASDAQ:MU) insider ownership is -10.84%. Integrated Silicon … Continue reading Semiconductor Stocks: Micron Technology (NASDAQ:MU), Integrated Silicon Solution (NASDAQ:ISSI), Spansion Inc. (NYSE:CODE), Netlist (NASDAQ:NLST)

SolarWinds (NYSE:SWI) Price Target Increased by Jefferies

On Wednesday, Jefferies raised it’s price target for SolarWinds (NYSE:SWI) to $57 from $51.  In a research note issued by Aaron Schwartz, he indicated that the company’s cash flow potential remains underappreciated.  The stock continues to be a stock favorite at Jefferies. Highlights of the note included: 20% license growth could serve as a baseline. Stable ASPs with recent levels, and productivity from 2013 sales … Continue reading SolarWinds (NYSE:SWI) Price Target Increased by Jefferies

Services Sector Active Stocks: Sirius XM Holdings (NASDAQ:SIRI), J.C. Penney (NYSE:JCP), E Commerce China Dangdang (NYSE:DANG), Comcast (NASDAQ:CMCSA)

Earlier last month, Sirius XM Holdings Inc’ majority owner Liberty Media Corp. (LMCA), which is controlled by media mogul John Malone, offered to buy around 48% of Sirius XM Holdings Inc. (SIRI) it does not already own in a deal that could be worth more than $10 billion. Sirius XM Holdings Inc. (NASDAQ:SIRI) stock performance was -1.11% in last session and finished the day at … Continue reading Services Sector Active Stocks: Sirius XM Holdings (NASDAQ:SIRI), J.C. Penney (NYSE:JCP), E Commerce China Dangdang (NYSE:DANG), Comcast (NASDAQ:CMCSA)

Biotech Gainers: Arrowhead Research (NASDAQ:ARWR), DARA Biosciences (NASDAQ:DARA), Synthetic Biologics (NYSEMKT:SYN), Oncothyreon (NASDAQ:ONTY)

Equities research analysts at Deutsche Bank assumed coverage on shares of Arrowhead Research Corp (NASDAQ:ARWR) in a research note issued to investors on Wednesday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $45.00 price target on the stock. Arrowhead Research Corp (NASDAQ:ARWR) stock performance was 24.46% in last session and finished the day at $26.31. Traded volume was 7,684,553 million shares in the … Continue reading Biotech Gainers: Arrowhead Research (NASDAQ:ARWR), DARA Biosciences (NASDAQ:DARA), Synthetic Biologics (NYSEMKT:SYN), Oncothyreon (NASDAQ:ONTY)

Services Sector Active Runners: SIRIUS XM Holding (NASDAQ:SIRI), Rite Aid (NYSE:RAD), Delta Air Lines (NYSE:DAL), American Airlines (NASDAQ:AAL)

Sirius XM Holding Inc (NASDAQ:SIRI) announced that Emmy award-winning actor, writer, and producer Seth MacFarlane will sit down for an intimate Q&A session with a select group of listeners for the SiriusXM “Town Hall” Series. SIRIUS XM Holding Inc (NASDAQ:SIRI) stock performance was 0.56% in last session and finished the day at $3.59. Traded volume was 46,800,394 million shares in the last session and the … Continue reading Services Sector Active Runners: SIRIUS XM Holding (NASDAQ:SIRI), Rite Aid (NYSE:RAD), Delta Air Lines (NYSE:DAL), American Airlines (NASDAQ:AAL)

Biotech Gainers: Insys Therapeutics Inc (NASDAQ:INSY), Oxygen Biotherapeutics (NASDAQ:OXBT), Halozyme Therapeutics (NASDAQ:HALO), Cytori Therapeutics (NASDAQ:CYTX)

Insys Therapeutics (NASDAQ:INSY) hit a new 52-week high during trading on Tuesday following a better than expected earnings announcement, AnalystRatings.NET reports. Insys Therapeutics Inc (NASDAQ:INSY) stock performance was 21.73% in last session and finished the day at $83.37. Traded volume was 1,203,992 million shares in the last session and the average volume of the stock remained 263.48 million shares. The beta of the stock remained … Continue reading Biotech Gainers: Insys Therapeutics Inc (NASDAQ:INSY), Oxygen Biotherapeutics (NASDAQ:OXBT), Halozyme Therapeutics (NASDAQ:HALO), Cytori Therapeutics (NASDAQ:CYTX)